Patents Assigned to NX Pharmagen
  • BIOMARKERS OF PRETERM BIRTH
    Publication number: 20140186332
    Abstract: The present disclosure relates to biomarkers of preterm birth, biomarkers of term birth, and methods of use thereof. In particular, the present disclosure provides methods of determining whether a pregnant woman is at an increased risk for premature delivery. The present disclosure further provides methods for decreasing a pregnant woman's risk for premature delivery.
    Type: Application
    Filed: March 12, 2013
    Publication date: July 3, 2014
    Applicant: NX Pharmagen
    Inventors: Alan M. EZRIN, Brian D. Brohman